ArticleSmall methods2026
Optimization of Fluorescent Nanoparticles Architecture for Efficient Brightness, FRET Efficiency and Biosensing.
Article in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Precise control over fluorophore localization within polymer nanoparticles remains a major challenge, limiting the rational optimization of brightness, Förster Resonance Energy Transfer (FRET), and biosensing performance. Here, we report architecturally controlled donor core-shell-crown fluorescent polymer nanoparticles synthesized via a controlled radical polymerization in miniemulsion through a one-pot process performed entirely in water at high solid content. The polymerizable BODIPY monomers are covalently incorporated into the polymer backbone, preventing dye leakage while enabling spatial confinement within defined compartments. By selectively positioning the dye in the core, the shell, or both, we decouple brightness and donor-acceptor distance effects. Core-confined dyes maximize brightness by reducing water-induced quenching, whereas shell-localized dyes enhance FRET efficiency (up to 75%) by minimizing donor-acceptor separation, revealing a brightness/distance trade-off analogous to that observed in inorganic nanomaterials. Exciton migration and multivalent surface functionalization further amplify energy transfer within each nano-object. In a competitive biotin-streptavidin proof of concept assay, nanoparticle brightness emerges as the dominant parameter controlling analytical sensitivity. The optimized sensor achieves a limit of detection of ∼4-8 nM in different buffers or artificial fluids, and using both a spectrofluorometer and a low-cost LED-based device, highlighting the potential of these scalable, metal-free nanotransducers for point-of-care biosensing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.